Now That SpaceX Is Public, Should You Ditch Tesla Stock?

SpaceX is described as having $19.3 billion in revenue, an $8.7 billion loss, and more than $30 billion in debt while burning nearly $20 billion per year, despite a $2 trillion market cap. Tesla is presented as the more mature and financially stronger company, with nearly $98 billion in annual sales, $7 billion in free cash flow, and about $30 billion more cash than debt. The article argues SpaceX looks even more overvalued than Tesla and suggests any future merger could favor SpaceX using its richer stock to buy Tesla.

Analysis

The key market misread is not whether Musk optionality is valuable; it is that investors are compressing two very different financing structures into the same “future story” bucket. A capital-intensive, cash-burning platform with a much lower margin of safety should not trade at a premium to a self-funding operating company unless there is near-certain step-function monetization, and that is not remotely the case here. In practice, the richer valuation is more vulnerable to multiple compression because it depends on investors sustaining a venture-style terminal value for years while funding needs remain elevated.

Second-order, the real competitor is not Tesla but capital allocation itself. If investors begin treating Musk exposure as a basket rather than a single-name bet, incremental flows can migrate toward the cleaner balance sheet and better cash conversion, especially in a risk-off tape where duration-like equities are derated first. That creates a reflexive loop: the more the market debates a roll-up or asset sharing model, the more Tesla becomes the implicit acquisition currency and the more its equity acts like a discounted claim on a control transaction rather than a standalone growth compounder.

The near-term catalyst path is asymmetric. Over the next 1-3 months, any weak delivery, margin, or funding headline should hit the lower-quality narrative harder because there is no fundamental cushion; over 12-24 months, the only real rescue is a credible monetization inflection that moves from story to audited cash flow. The contrarian angle is that the market may be underpricing deal optionality, but that cuts both ways: if a combination ever emerges, the transaction likely occurs on terms that transfer value from the cheaper, better-capitalized equity to the more expensive one, not vice versa.

Key Decisions for Investors

• Short the richer Musk exposure against the better-cash-generating peer on a relative-value basis over the next 1-3 months; the setup favors valuation mean reversion if sentiment cools and there is no immediate monetization milestone.
• If already long TSLA, finance the position by selling 3-6 month out-of-the-money calls into strength; the stock’s upside is highly path-dependent while implied volatility should stay elevated on merger/speculation headlines.
• Avoid initiating fresh long exposure to the higher-burn asset until there is evidence of narrowing losses or a credible revenue bridge; the risk/reward is poor because downside from multiple compression is immediate while upside requires years.
• For event-driven accounts, buy a small amount of long-dated upside optionality in the cheaper equity only if deal rumors intensify; the trade should be sized as a merger tail-risk hedge, not a core long.
• Monitor for any capital-raising or strategic-collaboration announcement over the next quarter; that is the point where the market can reprice both names sharply, but the first move is more likely to favor the cleaner balance sheet.